Cargando…
Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo
BACKGROUND: The immunological composition of the tumor microenvironment has a decisive influence on the biological course of cancer and is therefore of profound clinical relevance. In this study, we analyzed the cooperative effects of integrin β4 (ITGB4) on tumor cells and E-/P-selectin on endotheli...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022201/ https://www.ncbi.nlm.nih.gov/pubmed/36932441 http://dx.doi.org/10.1186/s13045-023-01413-9 |
_version_ | 1784908677813108736 |
---|---|
author | Genduso, Sandra Freytag, Vera Schetler, Daniela Kirchner, Lennart Schiecke, Alina Maar, Hanna Wicklein, Daniel Gebauer, Florian Bröker, Katharina Stürken, Christine Milde-Langosch, Karin Oliveira-Ferrer, Leticia Ricklefs, Franz L. Ewald, Florian Wolters-Eisfeld, Gerrit Riecken, Kristoffer Unrau, Ludmilla Krause, Linda Bohnenberger, Hanibal Offermann, Anne Perner, Sven Sebens, Susanne Lamszus, Katrin Diehl, Linda Linder, Stefan Jücker, Manfred Schumacher, Udo Lange, Tobias |
author_facet | Genduso, Sandra Freytag, Vera Schetler, Daniela Kirchner, Lennart Schiecke, Alina Maar, Hanna Wicklein, Daniel Gebauer, Florian Bröker, Katharina Stürken, Christine Milde-Langosch, Karin Oliveira-Ferrer, Leticia Ricklefs, Franz L. Ewald, Florian Wolters-Eisfeld, Gerrit Riecken, Kristoffer Unrau, Ludmilla Krause, Linda Bohnenberger, Hanibal Offermann, Anne Perner, Sven Sebens, Susanne Lamszus, Katrin Diehl, Linda Linder, Stefan Jücker, Manfred Schumacher, Udo Lange, Tobias |
author_sort | Genduso, Sandra |
collection | PubMed |
description | BACKGROUND: The immunological composition of the tumor microenvironment has a decisive influence on the biological course of cancer and is therefore of profound clinical relevance. In this study, we analyzed the cooperative effects of integrin β4 (ITGB4) on tumor cells and E-/P-selectin on endothelial cells within the tumor stroma for regulating tumor growth by shaping the local and systemic immune environment. METHODS: We used several preclinical mouse models for different solid human cancer types (xenograft and syngeneic) to explore the role of ITGB4 (shRNA-mediated knockdown in tumor cells) and E-/P-selectins (knockout in mice) for tumor growth; effects on apoptosis, proliferation and intratumoral signaling pathways were determined by histological and biochemical methods and 3D in vitro experiments; changes in the intratumoral and systemic immune cell composition were determined by flow cytometry and immunohistochemistry; chemokine levels and their attracting potential were measured by ELISA and 3D invasion assays. RESULTS: We observed a very robust synergism between ITGB4 and E-/P-selectin for the regulation of tumor growth, accompanied by an increased recruitment of CD11b(+) Gr-1(Hi) cells with low granularity (i.e., myeloid-derived suppressor cells, MDSCs) specifically into ITGB4-depleted tumors. ITGB4-depleted tumors undergo apoptosis and actively attract MDSCs, well-known to promote tumor growth in several cancers, via increased secretion of different chemokines. MDSC trafficking into tumors crucially depends on E-/P-selectin expression. Analyses of clinical samples confirmed an inverse relationship between ITGB4 expression in tumors and number of tumor-infiltrating leukocytes. CONCLUSIONS: These findings suggest a distinct vulnerability of ITGB4(Lo) tumors for MDSC-directed immunotherapies. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13045-023-01413-9. |
format | Online Article Text |
id | pubmed-10022201 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-100222012023-03-18 Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo Genduso, Sandra Freytag, Vera Schetler, Daniela Kirchner, Lennart Schiecke, Alina Maar, Hanna Wicklein, Daniel Gebauer, Florian Bröker, Katharina Stürken, Christine Milde-Langosch, Karin Oliveira-Ferrer, Leticia Ricklefs, Franz L. Ewald, Florian Wolters-Eisfeld, Gerrit Riecken, Kristoffer Unrau, Ludmilla Krause, Linda Bohnenberger, Hanibal Offermann, Anne Perner, Sven Sebens, Susanne Lamszus, Katrin Diehl, Linda Linder, Stefan Jücker, Manfred Schumacher, Udo Lange, Tobias J Hematol Oncol Research BACKGROUND: The immunological composition of the tumor microenvironment has a decisive influence on the biological course of cancer and is therefore of profound clinical relevance. In this study, we analyzed the cooperative effects of integrin β4 (ITGB4) on tumor cells and E-/P-selectin on endothelial cells within the tumor stroma for regulating tumor growth by shaping the local and systemic immune environment. METHODS: We used several preclinical mouse models for different solid human cancer types (xenograft and syngeneic) to explore the role of ITGB4 (shRNA-mediated knockdown in tumor cells) and E-/P-selectins (knockout in mice) for tumor growth; effects on apoptosis, proliferation and intratumoral signaling pathways were determined by histological and biochemical methods and 3D in vitro experiments; changes in the intratumoral and systemic immune cell composition were determined by flow cytometry and immunohistochemistry; chemokine levels and their attracting potential were measured by ELISA and 3D invasion assays. RESULTS: We observed a very robust synergism between ITGB4 and E-/P-selectin for the regulation of tumor growth, accompanied by an increased recruitment of CD11b(+) Gr-1(Hi) cells with low granularity (i.e., myeloid-derived suppressor cells, MDSCs) specifically into ITGB4-depleted tumors. ITGB4-depleted tumors undergo apoptosis and actively attract MDSCs, well-known to promote tumor growth in several cancers, via increased secretion of different chemokines. MDSC trafficking into tumors crucially depends on E-/P-selectin expression. Analyses of clinical samples confirmed an inverse relationship between ITGB4 expression in tumors and number of tumor-infiltrating leukocytes. CONCLUSIONS: These findings suggest a distinct vulnerability of ITGB4(Lo) tumors for MDSC-directed immunotherapies. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13045-023-01413-9. BioMed Central 2023-03-17 /pmc/articles/PMC10022201/ /pubmed/36932441 http://dx.doi.org/10.1186/s13045-023-01413-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Genduso, Sandra Freytag, Vera Schetler, Daniela Kirchner, Lennart Schiecke, Alina Maar, Hanna Wicklein, Daniel Gebauer, Florian Bröker, Katharina Stürken, Christine Milde-Langosch, Karin Oliveira-Ferrer, Leticia Ricklefs, Franz L. Ewald, Florian Wolters-Eisfeld, Gerrit Riecken, Kristoffer Unrau, Ludmilla Krause, Linda Bohnenberger, Hanibal Offermann, Anne Perner, Sven Sebens, Susanne Lamszus, Katrin Diehl, Linda Linder, Stefan Jücker, Manfred Schumacher, Udo Lange, Tobias Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo |
title | Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo |
title_full | Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo |
title_fullStr | Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo |
title_full_unstemmed | Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo |
title_short | Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo |
title_sort | tumor cell integrin β4 and tumor stroma e-/p-selectin cooperatively regulate tumor growth in vivo |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022201/ https://www.ncbi.nlm.nih.gov/pubmed/36932441 http://dx.doi.org/10.1186/s13045-023-01413-9 |
work_keys_str_mv | AT gendusosandra tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT freytagvera tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT schetlerdaniela tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT kirchnerlennart tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT schieckealina tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT maarhanna tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT wickleindaniel tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT gebauerflorian tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT brokerkatharina tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT sturkenchristine tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT mildelangoschkarin tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT oliveiraferrerleticia tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT ricklefsfranzl tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT ewaldflorian tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT wolterseisfeldgerrit tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT rieckenkristoffer tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT unrauludmilla tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT krauselinda tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT bohnenbergerhanibal tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT offermannanne tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT pernersven tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT sebenssusanne tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT lamszuskatrin tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT diehllinda tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT linderstefan tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT juckermanfred tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT schumacherudo tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo AT langetobias tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo |